TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $439,000 | -79.2% | 2,839 | -98.6% | 0.03% | -84.7% |
Q3 2015 | $2,111,000 | +553.6% | 198,770 | +8734.2% | 0.22% | +551.5% |
Q2 2015 | $323,000 | -9.0% | 2,250 | -10.6% | 0.03% | -15.4% |
Q1 2015 | $355,000 | -5.1% | 2,517 | -0.4% | 0.04% | -20.4% |
Q4 2014 | $374,000 | -52.5% | 2,526 | -50.6% | 0.05% | -64.7% |
Q3 2014 | $787,000 | +129.4% | 5,118 | +109.1% | 0.14% | +139.7% |
Q2 2014 | $343,000 | – | 2,448 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
Think Investments LP | 186,373 | $28,804,000 | 8.16% |
Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |